Compare FMX & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FMX | MDLN |
|---|---|---|
| Founded | 1890 | 1966 |
| Country | Mexico | United States |
| Employees | N/A | 45000 |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1B | 37.4B |
| IPO Year | 1998 | N/A |
| Metric | FMX | MDLN |
|---|---|---|
| Price | $128.11 | $38.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 23 |
| Target Price | ★ $113.17 | $50.48 |
| AVG Volume (30 Days) | 502.9K | ★ 10.6M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.30% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.20 | $10.88 |
| Revenue Next Year | $8.32 | $7.69 |
| P/E Ratio | ★ $40.94 | $658.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $83.08 | $32.82 |
| 52 Week High | $130.55 | $50.88 |
| Indicator | FMX | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 59.79 | 57.86 |
| Support Level | $118.62 | $38.50 |
| Resistance Level | $130.55 | $44.89 |
| Average True Range (ATR) | 3.29 | 1.60 |
| MACD | -0.07 | 0.50 |
| Stochastic Oscillator | 77.19 | 94.86 |
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.